Cellebrite DI (CLBT) Cost of Revenue (2020 - 2025)

Cellebrite DI's Cost of Revenue history runs 6 years deep, the most recent figure standing at $38.6 million for Q4 2025.

• In Q4 2025, Cost of Revenue rose 8.55% year-over-year to $38.6 million; the TTM figure through Dec 2025 stood at $154.8 million (up 16.94% YoY), while the FY2025 annual figure was $154.8 million, up 147.33% from the prior year.
• Cost of Revenue was $38.6 million for Q4 2025 at Cellebrite DI, down from $38.8 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $38.8 million in Q3 2025 to a low of $16.5 million in Q1 2021.
• Historically, Cost of Revenue has averaged $28.6 million across 5 years, with a median of $27.2 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue surged 40.81% in 2022, then climbed 5.11% in 2023.
• A 5-year view of Cost of Revenue shows it stood at $21.2 million in 2021, then advanced by 11.44% to $23.7 million in 2022, then gained by 25.03% to $29.6 million in 2023, then increased by 20.04% to $35.5 million in 2024, then rose by 8.55% to $38.6 million in 2025.
• The last three Cost of Revenue figures came in at $38.6 million (Q4 2025), $38.8 million (Q3 2025), and $38.7 million (Q2 2025), per Business Quant data.